Prof Greg Hannon elected to EMBO Membership
TheĀ European Molecular Biology Organization (orĀ EMBO) today announced that Prof Greg Hannon, Director of the Cambridge Institute, is among 62 outstanding life sciences researchers who have been elected as new members.
āEMBO Members are leading scientists working across all of the life sciences. They also strengthen the research community in Europe and beyond through their international collaborations and connections,ā says EMBO Director Maria Leptin.
The members are actively involved in the execution of the organizationās initiatives by serving on EMBO Council, Committees and Editorial Boards, by evaluating applications for EMBO funding, by mentoring young scientists and by providing suggestions and feedback on activities.
Related News
See all news-
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more